Peripheral thyroid dysfunction in depression

References

• Agid O, Lerer B. Algorithm-based treatment of major depression in an outpatient clinic: Clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation. Int J Neuropsychopharmacol 2003; 6: 41–49
   PubMed Web of Science ®Google Scholar
• Altshuler LL, Frye MA, Gitlin MJ. Acceleration and augmentation strategies for treating bipolar depression. Biol Psychiatry 2003; 53: 691–700
   PubMed Web of Science ®Google Scholar
• Banki C, Vojnik M, Arato M, Papp Z, Kovacs Z. Dexamethasone suppression and multiple hormonal responses (TSH, prolactin and growth hormone) to TRH in some psychiatric disorders. Eur Arch Psychiatry Neurol Sci 1985; 235: 32–37
   PubMedGoogle Scholar
• Bauer M, Baur H, Berghofer A, Strohle A, Hellweg R, Muller-Oerlinghausen B, Baumgartner A. Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disorders. J Affect Disord 2002; 68: 285–94
   PubMedGoogle Scholar
• Bauer M, Whybrow P, Winokur A. Rapid cycling bipolar affective disorder I: Association with grade I hypothyroidism. Arch Gen Psychiatry 1990; 47: 427–432
   PubMed Web of Science ®Google Scholar
• Bauer M. Thyroid hormone augmentation with levothyroxine in bipolar depression. Bipolar Disord 2002; 4(Suppl 1)109–110
   PubMedGoogle Scholar
• Berlin I, Payan C, Corruble E, Puech A. Serum thyroid-stimulating-hormone concentration as an index of severity of major depression. Int J Neuropsychopharmcol 1999; 2: 105–110
   PubMed Web of Science ®Google Scholar
• Bermudez F, Surks M, Oppenheimer J. High incidence of decreased serum triiodothyroine concentration in patients with non-thyroidal disease. J Clin Endocrinol Metab 1975; 41: 27–31
   PubMed Web of Science ®Google Scholar
• Broe G, Henderson A, Creasey H, McCusker E, Korten A, Jorm A, Longley W, Anthony J. A case control study of Alzheimer's disease in Austria. Neurology 1990; 40: 1698–1707
   PubMed Web of Science ®Google Scholar
• Bunevicius R, Kazanavicius G, Telksnys A. Thyrotropin response to TRH stimulation in depressed patients with autoimmune thyroiditis. Biol Psychiatry 1994; 36: 543–547
   PubMedGoogle Scholar
• Burch H. Abnormal thyroid function test results in euthyroid persons. Principles and practice of endocrinology and metabolism, K Becker. JB Lippincott Company, Philadelphia, PA 1995; 323–332
   Google Scholar
• Cadieux RJ. Practical management of treatment-resistant depression. Am Fam Phys 1998; 58: 2059–2062
   PubMedGoogle Scholar
• Carta M, Hardoy M, Boi M, Mariotti S, Carpiniello B, Usai P. Association between panic disorder, major depressive disorder and celiac disease: A possible role of thyroid autoimmunity. J Psychosom Res 2002; 53: 789–793
   PubMed Web of Science ®Google Scholar
• Carta M, Hardoy M, Usai P, Carpiniello B, Angst J. Recurrent brief depression in celiac disease. J Psychosom Res 2003; 55: 573–574
   PubMed Web of Science ®Google Scholar
• Cole D, Thase M, Mallinger A, Soares J, Luther J, Kupfer D, Frank E. Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function. Am J Psychiatry 2002; 159: 116–121
   PubMed Web of Science ®Google Scholar
• Custro N, Scafidi V, LoBaido R, Nastri L, Abbate G, Cuffaro M, Gallo S, Vienna G, Notarbartolo A. Subclinical hypothyroidism resulting from autoimmune thyroiditis in female patients with endogenous depression. J Endocrinol Invest 1994; 17: 641–646
   PubMedGoogle Scholar
• Dally P, Rohde P. Comparison of antidepressant drugs in depressive illnesses. Lancet 1961; i: 18–20
   Google Scholar
• David M, Owen J, Abraham G, Delva N, Southmayd S, Wooltorton E, Lawson J. Thyroid function and response to 48-hour sleep deprivation in treatment-resistant depressed patients. Biol Psychiatry 2000; 48: 323–326
   PubMed Web of Science ®Google Scholar
• DeMendonηaLima C, Vandel S, Bonin B, Bertschy G, Bizouard P. Thyroid function in depressed patients. Encephale 1996; 22: 85–94
   Google Scholar
• Dording CM. Antidepressant augmentation and combinations. Psychiatr Clin North Am 2000; 23: 743–55
   PubMedGoogle Scholar
• Duval F, Mokrani M, Bailey P, Correa H, Diep T, Crocq M, Macher J. Thyroid axis activity and serotonin function in major depressive episode. Psychoneuroendocrinology 1999; 24: 695–712
   PubMed Web of Science ®Google Scholar
• Elenkov I, Chrousos G. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann NY Acad Sci 2002; 966: 290–303
   PubMed Web of Science ®Google Scholar
• Evans D, Golden R. The dexamethasone suppression test: A review. Handbook of clinical psychoneuroendocrinology, P Loosen. John Wiley and Sons, New York 1987; 313–335
   Google Scholar
• Fava M. New approaches to the treatment of refractory depression. J Clin Psychiatry 2000; 61(Suppl 1)26–32
   PubMedGoogle Scholar
• Fava M, Labbate L, Abraham M, Rosenbaum J. Hypothyroidism and hyperthyroidism in major depression revisited. J Clin Psychiatry 1995; 56: 186–192
   PubMed Web of Science ®Google Scholar
• Fountoulakis K, Fotiou F, Iacovides A, Karamouzis M, Goulas A, Demetriadou A, Kaprinis G. Relationship between pupillometric findings, DST and melancholia. Acta Psychiatr Belg 2001; 101: 202–235
   Google Scholar
• Fountoulakis K, Iacovides A, Grammaticos P, Kaprinis G, Bech P. Thyroid function and clinical subtypes of major depression: An exploratory study. BMC Psychiatry 2004; 4: 6
   PubMed Web of Science ®Google Scholar
• Fountoulakis K, Iacovides A, Nimatoudis I, Kaprinis G, Ierodiakonou C. Comparison of the diagnosis of melancholic and atypical features according to DSM-IV and somatic syndrome according to ICD-10 in patients suffering from major depression. Eur Psychiatry 1999; 14: 426–434
   PubMedGoogle Scholar
• Frye M, Dunn R, Gary K, Kimbrell T, Callahan A, Luckenbaugh D, Cora-Locatelli G, Vanderham E, Winokur A, Post R. Lack of correlation between cerebrospinal fluid thyrotropin-releasing hormone (TRH) and TRH-stimulated thyroid-stimulating hormone in patients with depression. Biol Psychiatry 1999; 45: 1049–1052
   PubMedGoogle Scholar
• Gewirtz G, Malaspina D, Hatterer J, Feureisen S, Klein D, Gorman J. Occult thyroid dysfunction in patients with refractory depression. Am J Psychiatry 1988; 145: 1012–1014
   PubMed Web of Science ®Google Scholar
• Gold M, Pottash A, Extein I. Symptomless autoimmune thyroiditis in depression. Psychiatry Res 1982; 6: 261–269
   PubMedGoogle Scholar
• Haggerty J, Evans D, Golden R, Pedersen C, Simon J, Nemeroff C. The presence of antithyroid antibodies in patients with affective and nonaffective psychiatric disorders. Biol Psychiatry 1990; 27: 51–60
   PubMed Web of Science ®Google Scholar
• Haggerty J, Stern R, Mason G, Beckwith J, Morey C, Prange A. Subclinical hypothyroidism: A modifiable risk factor for depression?. Am J Psychiatry 1993; 150: 508–510
   PubMed Web of Science ®Google Scholar
• Haggerty J, Silva S, Marquardt M, Mason G, Chang H, Evans D, Golden R, Pedersen C. Prevalence of antithyroid antibodies in mood disorders. Depression Anxiety 1997; 5: 91–96
   PubMedGoogle Scholar
• Harris B. Postpartum depression and thyroid antibody status. Thyroid 1999; 9: 699–703
   PubMedGoogle Scholar
• Harris B, Fung H, Johns S, Kologlu M, Bhatti R, McGregor A, Richards C, Hall R. Transient post-partum thyroid dysfunction and postnatal depression. J Affect Disord 1989; 17: 243–249
   PubMed Web of Science ®Google Scholar
• Harris B, Othman S, Davies J, Weppner G, Richards C, Newcombe R, Lazarus J, Parkes A, Hall R, Phillips D. Association between postpartum thyroid dysfunction and thyroid antibodies and depression. Br Med J (Clin Res Edn) 1992; 305: 152–156
   PubMed Web of Science ®Google Scholar
• Harris B, Oretti R, Lazarus J, Parkes A, John R, Richards C, Newcombe R, Hall R. Randomised trial of thyroxine to prevent postnatal depression in thyroid-antibody-positive women. Br J Psychiatry 2002; 180: 327–330
   PubMedGoogle Scholar
• Heyman A, Wilkinson W, Stafford J. Alzheimer's disease: A study of epidemiological aspects. Ann Neurol 1984; 15: 335–341
   PubMed Web of Science ®Google Scholar
• Howland R. Thyroid dysfunction in refractory depression: implications for pathophysiology and treatment. J Clin Psychiatry 1993; 54: 47–54
   PubMed Web of Science ®Google Scholar
• Iacovides A, Fountoulakis K, Grammaticos P, Ierodiakonou C. Difference in symptom profile between generalized anxiety disorder and anxiety secondary to hyperthyroidism. Int J Psychiatry Med 2000; 30: 71–81
   PubMedGoogle Scholar
• Jackson I. The thyroid axis and depression Thyroid 1998; 8: 951–956
   PubMed Web of Science ®Google Scholar
• Jankovic BD. Neural tissue hypersensitivity in psychiatric disorders with immunologic features. J Immunol 1985; 135: 853–857s
   Web of Science ®Google Scholar
• Joffe R. Antithyroid antibodies in major depression. Acta Psychiatr Scand 1987; 76: 598–599
   PubMed Web of Science ®Google Scholar
• Joffe R. Peripheral thyroid hormone levels in treatment resistant depression. Biol Psychiatry 1999; 45: 1053–1055
   PubMedGoogle Scholar
• Joffe R, Marriott M. Thyroid hormone levels and recurrence of major depression. Am J Psychiatry 2000; 157: 1689–1691
   PubMed Web of Science ®Google Scholar
• Joffe R, Bagby R, Levitt A. The thyroid and melancholia. Psychiatry Res 1992; 42: 73–80
   PubMedGoogle Scholar
• Joffe R, Segal Z, Singer W. Change in thyroid hormone levels following response to cognitive therapy for major depression. Am J Psychiatry 1996; 153: 411–413
   PubMed Web of Science ®Google Scholar
• Joffe RT. Refractory depression: treatment strategies, with particular reference to the thyroid axis. J Psychiatry Neurosci 1997; 22: 327–331
   PubMedGoogle Scholar
• Joffe, RT. 1998. The use of thyroid supplements to augment antidepressant medication. J Clin Psychiatry, 59(Suppl 5):26–29; Discussion 30–31.
   PubMedGoogle Scholar
• Joffe RT, Sokolov ST. Thyroid hormones, the brain, and affective disorders. Crit Rev Neurobiol 1994; 8: 45–63
   PubMedGoogle Scholar
• Joffe RT, Sokolov ST. Thyroid hormone treatment of primary unipolar depression: A review. Int J Neuropsychopharmacol 2000; 3: 143–147
   PubMed Web of Science ®Google Scholar
• Kaptein E. Clinical application of free thyroxine determinations. Clin Lab Med 1993; 13: 653–672
   PubMedGoogle Scholar
• Kent G, Stuckey B, Allen J, Lambert T, Gee V. Postpartum thyroid dysfunction: Clinical assessment and relationship to psychiatric affective morbidity. Clin Endocrinol 1999; 51: 429–438
   PubMed Web of Science ®Google Scholar
• Kjellman B, Ljunggren J, Beck-Friis J, Wetterberg L. Effect of TRH on TSH and prolactin levels in affective disorders. Psychiatry Res 1985; 14: 353–363
   PubMedGoogle Scholar
• Kocsis J, Davis J, Katz M, Koslow S, Stokes P, Casper R, Redmond D. Depressive behavior and hyperactive adrenocortical function. Am J Psychiatry 1985; 142: 1291–1298
   PubMedGoogle Scholar
• Kokmen E, Beard R, Chandra V, Offord K, Schoenberg B, Ballard D. Clinical risk factors for Alzheimer's disease: A population-based case-control study. Neurology 1991; 41: 1393–1397
   PubMed Web of Science ®Google Scholar
• Konig F, Hauger B, vonHippel C, Wolfersdorf M, Kaschka W. Effect of paroxetine on thyroid hormone levels in severely depressed patients. Neuropsychobiology 2000; 42: 135–138
   PubMedGoogle Scholar
• Kuijpens J, Vader H, Drexhage H, Wiersinga W, van Son M, Pop V. Thyroid peroxidase antibodies during gestation are a marker for subsequent depression postpartum. Eur J Endocrinol 2001; 145: 579–584
   PubMed Web of Science ®Google Scholar
• Leentjens AF, Kappers EJ. Persistent cognitive defects after corrected hypothyroidism. Psychopathology 1995; 28: 235–237
   PubMed Web of Science ®Google Scholar
• Legros S, Mendlewicz J, Wybran J. Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders. Eur Arch Psychiatry Neurol Sci 1985; 265: 9–11
   Google Scholar
• Liebowitz M, Quitkin F, Stewart J, McGrath P, Harrison W, Markowitz J, Rabkin J, Tricamo E, Goetz D, Klein D. Antidepressant specificity in atypical depression. Arch Gen Psychiatry 1988; 45: 129–137
   PubMed Web of Science ®Google Scholar
• Loosen P. The TRH-induced TSH response in psychiatric patients: A possible neuroendocrine marker. Psychoneuroendocrinology 1985; 10: 237–260
   PubMedGoogle Scholar
• Lucas A, Pizarro E, Granada M, Salinas I, Sanmarti A. Postpartum thyroid dysfunction and postpartum depression: are they two linked disorders?. Clin Endocrinol 2001; 55: 809–814
   PubMedGoogle Scholar
• Maes M, Meltzer H, Cosyns P, Suy E, Schotte C. An evaluation of basal hypothalamic–pituitary–thyroid axis function in depression: Results of a large-scaled and controlled study. Psychoneuroendocrinology 1993; 18: 607–620
   PubMed Web of Science ®Google Scholar
• Maes M, D'Hondt P, Blockx P, Cosyns P. A further investigation of basal HPT axis function in unipolar depression: Effects of diagnosis, hospitalization, and dexamethasone administration. Psychiatry Res 1994a; 51: 185–201
   PubMedGoogle Scholar
• Maes M, Scharp? S, Cosyns P, Meltzer H. Relationships between basal hypothalamic-pituitary-thyroid-axis activity and plasma haptoglobin levels in depression. J Psychiatr Res 1994b; 28: 123–134
   PubMedGoogle Scholar
• Marangell, LB. 2000. Augmentation of standard depression therapy. Clin Ther, 22(Suppl A):A25–38; Discussion A39–41.
   Google Scholar
• Marchesi C, Chiodera P, DeRisio C, Dassζ L, Govi A, DeFerri A, Piagneri B, Minelli R, Bianconi L, Gnudi A. Dopaminergic control of TSH secretion in endogenous depression. Psychiatry Res 1988; 25: 277–282
   PubMedGoogle Scholar
• Mendlewicz J, Hubain P, Koumakis C. Further investigation of the dexamethasone suppression test in affective illness: Relationship to clinical diagnosis and therapeutic response. Neuropsychobiology 1984; 12: 23–26
   PubMedGoogle Scholar
• Musselman, DL, Nemeroff, CB. 1996. Depression and endocrine disorders: focus on the thyroid and adrenal system. Br J Psychiatry Suppl. 123–128.
   PubMedGoogle Scholar
• Nelson C, Davis J. DST studies in psychotic depression: A meta-analysis. Am J Psychiatry 1997; 154: 1497–1503
   PubMed Web of Science ®Google Scholar
• Nemeroff C. Clinical significance of psychoneuroendocrinology in psychiatry: Focus on the thyroid and adrenal. J Clin Psychiatry 1989; 50(Suppl)13–20
   PubMedGoogle Scholar
• Nemeroff C, Simon J, Haggerty J, Evans D. Antithyroid antibodies in depressed patients. Am J Psychiatry 1985; 142: 840–843
   PubMed Web of Science ®Google Scholar
• Nemeroff CB. Augmentation strategies in patients with refractory depression. Depress Anxiety 1996; 4: 169–181
   PubMedGoogle Scholar
• O'Donnell M, Silove D, Wakefield D. Current perspectives on immunology and psychiatry. Aust NZ J Psychiatry 1988; 22: 366–382
   PubMed Web of Science ®Google Scholar
• Ordas DM, Labbate LA. Routine screening of thyroid function in patients hospitalized for major depression or dysthymia?. Ann Clin Psychiatry 1995; 7: 161–165
   PubMedGoogle Scholar
• Orth D, Shelton R, Nicholson W, Beck-Peccoz P, Tomarken A, Persani L, Loosen P. Serum thyrotropin concentrations and bioactivity during sleep deprivation in depression. Arch Gen Psychiatry 2001; 58: 77–83
   PubMedGoogle Scholar
• Overall J, Hollister L, Johnson M. Nosology of depression and differential response to drugs. J Am Med Assoc 1966; 195: 946–950
   PubMed Web of Science ®Google Scholar
• Pedersen C. Postpartum mood and anxiety disorders: A guide for the nonpsychiatric clinician with an aside on thyroid associations with postpartum mood. Thyroid 1999; 9: 691–697
   PubMedGoogle Scholar
• Pop V, Maartens L, Leusink G, vanSon M, Knottnerus A, Ward A, Metcalfe R, Weetman A. Are autoimmune thyroid dysfunction and depression related?. J Clin Endocrinol Metab 1998; 83: 3194–3197
   PubMed Web of Science ®Google Scholar
• Post RM, Leverich GS, Denicoff KD, Frye MA, Kimbrell TA, Dunn R. Alternative approaches to refractory depression in bipolar illness. Depress Anxiety 1997; 5: 175–89
   PubMedGoogle Scholar
• Pridmore S, Turnier-Shea Y. Medication options in the treatment of treatment-resistant depression. Aust NZ J Psychiatry 2004; 38: 219–225
   PubMed Web of Science ®Google Scholar
• Rao M, Vartzopoulos D, Fels K. Thyroid function in anxious and depressed patients. Pharmacopsychiatry 1989; 22: 66–70
   PubMedGoogle Scholar
• Rao M, Ruhrmann S, Retey B, Liappis N, Fuger J, Kraemer M, Kasper S, Møller H. Low plasma thyroid indices of depressed patients are attenuated by antidepressant drugs and influence treatment outcome. Pharmacopsychiatry 1996; 29: 180–186
   PubMedGoogle Scholar
• Reed L, Pangaro L. Physiology of the thyroid gland I: Synthesis and release, iodine metabolism and binding and transport. Principles and practice of endocrinology and metabolism, K Becker. JB Lippincott Company, Philadelphia, PA 1995; 285–291
   Google Scholar
• Roth M. The phenomenology of depressive states. Can Psychiatr Assoc J 1959; 4(Suppl)32–52
   PubMedGoogle Scholar
• Rupprecht R, Rupprecht C, Rupprecht M, Noder M, Mahlstedt J. Triiodothyronine, thyroxine, and TSH response to dexamethasone in depressed patients and normal controls. Biol Psychiatry 1989; 25: 22–32
   PubMedGoogle Scholar
• Sagud M, Pivac N, Muck-Seler D, Jakovljevic M, Mihaljevic-Peles A, Korsic M. Effects of sertraline treatment on plasma cortisol, prolactin and thyroid hormones in female depressed patients. Neuropsychobiology 2002; 45: 139–43
   PubMedGoogle Scholar
• Sargant W. Some newer drugs in the treatment of depression and their relation to other somatic treatments. Psychosomatics 1960; 1: 14–17
   Google Scholar
• Schindler BA. Stress, affective disorders, and immune function. Med Clin North Am 1985; 69: 585–597
   PubMed Web of Science ®Google Scholar
• Schule, C, Baghai, T. C, Alajbegovic, L, Schwarz, M, Zwanzger, P, Eser, D, Schaaf, L, Moller, H. J, Rupprecht, R. 2005. The influence of 4-week treatment with sertraline on the combined T3/TRH test in depressed patients. Eur Arch Psychiatry Clin Neurosci, in press.
   PubMedGoogle Scholar
• Shelton, RC. 1999. Treatment options for refractory depression. J Clin Psychiatry, 60(Suppl 4):57–61; Discussion 62–63.
   PubMedGoogle Scholar
• Sher L, Rosenthal N, Wehr T. Free thyroxine and thyroid-stimulating hormone levels in patients with seasonal affective disorder and matched controls. J Affect Disord 1999; 56: 195–199
   PubMed Web of Science ®Google Scholar
• Staner L, De La Fuente JM, Kerkhofs M, Linkowski P, Mendlewicz J. Biological and clinical features of recurrent brief depression: A comparison with major depressed and healthy subjects. J Affect Disord 1992; 26: 241–245
   PubMedGoogle Scholar
• Stein M, Uhde T. Autoimmune thyroiditis and panic disorder. Am J Psychiatry 1989; 146: 259–260
   PubMedGoogle Scholar
• Sullivan G, Hatterer J, Herbert J. Low levels of transthyretin in the CSF of depressed patients. Am J Psychiatry 1999; 156: 710–715
   PubMed Web of Science ®Google Scholar
• Sussman, N, Joffe, RT. 1998. Introduction: Augmentation of antidepressant medication. J Clin Psychiatry, 59(Suppl 5):3–4; Discussion 70–73.
   PubMedGoogle Scholar
• Szuba M, O'Reardon J, Rai A, Snyder-Kastenberg J, Amsterdam J, Gettes D, Wassermann E, Evans D. Acute mood and thyroid stimulating hormone effects of transcranial magnetic stimulation in major depression. Biol Psychiatry 2001; 50: 22–27
   PubMed Web of Science ®Google Scholar
• Thase, ME, Howland, RH, Friedman, ES. 1998. Treating antidepressant nonresponders with augmentation strategies: An overview. J Clin Psychiatry, 59(Suppl 5):5–12; Discussion 13–15.
   PubMed Web of Science ®Google Scholar
• Van Praag H, Uleman A, Spitz J. The vital syndrome interview. Psychiatr Neurol Neurochir 1965; 68: 329–349
   PubMedGoogle Scholar
• vanWest D, Maes M. Activation of the inflammatory response system: A new look at the etiopathogenesis of major depression. Neuroendocrinol Lett 1999; 20: 11–17
   PubMedGoogle Scholar